In a stunning about-face, the U.S. Food and Drug Administration (FDA) has been forced to issue a warning that Covid mRNA “vaccines” come with a real, measurable, and potentially long-term risk of heart damage, especially in young men and teenage males.
The FDA is only now acknowledging what critics have warned about for years.
Newly appointed FDA Commissioner Dr. Vinay Prasad issued a class-wide safety label update for all Covid mRNA injections.
The federal agency is finally admitting to the elevated risk of myocarditis and related cardiac injury among those who received the shots.
However, while the warning may be new, the data isn’t.
The FDA has had access to this information for years but chose to remain silent.
As Slay News has previously reported, Myocarditis is a “silent killer” at the center of the sudden deaths crisis that emerged after the Covid injections were rolled out for public use in early 2021.
Myocarditis is the inflammation of the heart muscle (myocardium).
The condition reduces heart function, causing strokes, blood clots, cardiac arrest, or even sudden death.
Myocarditis is described by cardiologists as a “silent killer” as it’s often symptomless, leaving many sufferers unaware that they have it until they suffer a side effect, such as a cardiac arrest, when it’s too late.
According to the U.S. Centers for Disease Control and Prevention (CDC), myocarditis is a known side effect of Covid mRNA “vaccines.”
Prasad issued the new warning in an official FDA video message.
WATCH:
The FDA’s new Safety Labeling Change (SLC) follows a tidal wave of pressure and a growing body of international research.
It specifically cites long-term cardiac MRI findings showing persistent late gadolinium enhancement (LGE).
LGE is a red flag for myocardial fibrosis, permanent scarring of the heart muscle often tied to poor clinical outcomes.
Yet despite the clear signal, the FDA’s updated warning remains deliberately vague and insufficient.
The FDA pegs the risk of myocarditis in males aged 12–24 at roughly 1 in 37,000.
However, independent and international studies have reported rates as high as 1 in 3,000.
60–70% of affected patients showed ongoing abnormalities on cardiac MRIs months later, meaning the damage isn’t just acute; it may be long-term or even permanent.
The FDA’s own BEST system (its vaccine safety monitoring platform) can’t even distinguish risks by vaccine brand.
This failure continues to obscure the higher myocarditis risks associated with Moderna’s mRNA platform.
Despite finally slapping a warning label on the shots, the FDA has refused to name names.
There is still no brand-specific risk guidance, despite overwhelming evidence that Moderna’s shot carries a higher risk of myocarditis than Pfizer’s, particularly in young men.
To many, the continued silence appears to be corporate protection, regulatory cowardice, or both.
Unlike several European countries, which banned or suspended Moderna for younger age groups years ago, the FDA has taken zero meaningful steps to mitigate harm for the most vulnerable.
Those affected are young, healthy Americans who were coerced, guilted, or mandated into taking shots they likely never needed.
Even now, there is:
- No new guidance for the treatment of the thousands injured.
- No support for long-term cardiac monitoring.
- No compensation framework for the disabled and bereaved.
The FDA’s safety label may have changed, but its posture hasn’t.
Still no accountability or justice.
Dr. Prasad’s appointment was touted as a shift toward integrity.
However, this move, while necessary, feels more like damage control than genuine reform.
A label update is a belated admission of failure.
The agency admits it suppressed early safety signals, some under political pressure.
Yet there is still no reckoning.
There are still no hearings, prosecutions, or apologies.
For a federal health agency that claimed to “follow the science,” it took nearly three years and untold numbers of injuries and deaths to acknowledge a risk that critics, whistleblowers, and independent researchers were screaming about since 2021.
And now, the very regulators who dismissed legitimate concerns are trying to portray themselves as reformers.
The FDA can update labels all it wants, but the real question remains:
Will anyone be held accountable for the catastrophic damage already done?
READ MORE – Japan Sounds Alarm as Autopsies Find ‘Micro-Scars’ in Hearts of ‘Boosted’ Corpses
Be the first to comment